Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M
Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy.
Allergy. 2008 Feb;63(2):176-80. doi: 10.1111/j.1398-9995.2007.01514.x. Epub 2007 Oct 24.
Patients with chronic urticaria (CU) frequently show signs of thrombin generation as a result of the activation of the extrinsic pathway of coagulation and signs of fibrinolysis as shown by slightly increased mean D-dimer plasma levels. Here, we studied patients with severe CU to see whether the activation of coagulation and fibrinolysis parallels the severity of the disease.
Eight consecutive patients with severe exacerbations of CU and 13 with slight CU were studied. Plasma prothrombin fragment F(1+2) as well as D-dimer were measured by ELISA. Serum histamine-releasing activity was assessed by basophil histamine release assay. Seventy-four normal subjects were used as controls.
In patients with severe CU, median levels of both D-dimer (11.20 nmol/l) and F(1+2) (592 pmol/l) largely exceeded those found in patients with slight CU [D-dimer: 2.66 nmol/l (P = 0.001) and F(1+2): 228 pmol/l (P = 0.003)] and in normal subjects [D-dimer: 1.41 nmol/l (P = 0.0001) and F(1+2): 159 pmol/l (P = 0.0001)]. Sera from 25% of patients with severe CU and 31% of those with slight CU, but from none of normal subjects, showed in vitro histamine-releasing activity. D-dimer and F(1+2) levels were significantly correlated each other (r = 0.64, P = 0.002) and with CU severity score (r = 0.80-0.90, P = 0.0001), but no correlation was observed between serum histamine-releasing activity and coagulation parameters or severity score.
Severe exacerbations of CU are associated with a strong activation of coagulation cascade and fibrinolysis. Whether this activation is the cause of CU or acts as an amplification system is still a matter of debate.
慢性荨麻疹(CU)患者常因凝血外源性途径激活而出现凝血酶生成迹象,且平均血浆D - 二聚体水平略有升高,显示有纤维蛋白溶解迹象。在此,我们研究了重度CU患者,以观察凝血和纤维蛋白溶解的激活是否与疾病严重程度平行。
研究了8例连续重度加重的CU患者和13例轻度CU患者。采用酶联免疫吸附测定法(ELISA)检测血浆凝血酶原片段F(1 + 2)以及D - 二聚体。通过嗜碱性粒细胞组胺释放试验评估血清组胺释放活性。74名正常受试者作为对照。
重度CU患者中,D - 二聚体(11.20 nmol/l)和F(1 + 2)(592 pmol/l)的中位数水平大大超过轻度CU患者[D - 二聚体:2.66 nmol/l(P = 0.001)和F(1 + 2):228 pmol/l(P = 0.003)]以及正常受试者[D - 二聚体:1.41 nmol/l(P = 0.0001)和F(1 + 2):159 pmol/l(P = 0.0001)]。25%的重度CU患者血清和31%的轻度CU患者血清显示出体外组胺释放活性,但正常受试者血清均未显示。D - 二聚体和F(1 + 2)水平彼此显著相关(r = 0.64,P = 0.002),且与CU严重程度评分相关(r = 0.80 - 0.90,P = 0.0001),但血清组胺释放活性与凝血参数或严重程度评分之间未观察到相关性。
重度CU加重与凝血级联反应和纤维蛋白溶解的强烈激活相关。这种激活是CU的病因还是作为一个放大系统仍存在争议。